financetom
Business
financetom
/
Business
/
Baidu's Q1 Adjusted Earnings, Revenue Increase
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Baidu's Q1 Adjusted Earnings, Revenue Increase
May 16, 2024 3:15 AM

05:51 AM EDT, 05/16/2024 (MT Newswires) -- Baidu ( BIDU ) reported Q1 adjusted earnings Thursday of 19.91 Chinese renminbi ($2.76) per diluted American depositary share, up from 16.10 renminbi a year earlier.

Analysts polled by Capital IQ expected 15.81 renminbi.

Revenue for the quarter ended March 31 was 31.51 billion renminbi, up from 31.14 billion renminbi a year earlier.

Analysts surveyed by Capital IQ expected 31.41 billion renminbi.

Price: 111.12, Change: +0.37, Percent Change: +0.33

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tiziana Life Sciences Shares Rise Pre-Bell After Chairman Gabriele Cerrone Buys 25,000 Shares
Tiziana Life Sciences Shares Rise Pre-Bell After Chairman Gabriele Cerrone Buys 25,000 Shares
Sep 5, 2025
08:46 AM EDT, 09/05/2025 (MT Newswires) -- Tiziana Life Sciences ( TLSA ) said Friday that Executive Chairman Gabriele Cerrone bought 25,000 common shares at $1.60 per share. The purchase brings Cerrone's total holding to 43,277,143 shares or about 36.3% of issued share capital, the biopharmaceutical firm said. Shares were up 3.8% in recent premarket activity. ...
Update: Quanex Shares Fall Pre-Ball After Fiscal Q3 Profit Misses Expectations, Fiscal 2025 Guidance Cut
Update: Quanex Shares Fall Pre-Ball After Fiscal Q3 Profit Misses Expectations, Fiscal 2025 Guidance Cut
Sep 5, 2025
08:41 AM EDT, 09/05/2025 (MT Newswires) -- (Updates with recent stock movement in the headline and first paragraph.) Quanex Building Products ( NX ) shares were down over 23% in recent premarket activity Friday after the company reported fiscal Q3 adjusted earnings that fell short of expectations and cut its fiscal 2025 net sales outlook. The company reported fiscal Q3...
CERo Therapeutics Says FDA Grants Fast Track Designation to Potential Leukemia Treatment
CERo Therapeutics Says FDA Grants Fast Track Designation to Potential Leukemia Treatment
Sep 5, 2025
08:46 AM EDT, 09/05/2025 (MT Newswires) -- CERo Therapeutics ( CERO ) said Friday that the US Food and Drug Administration has granted fast track designation to its CER-1236 investigational compound as potential treatment for acute myeloid leukemia. The designation, which is on top of the existing orphan drug designation for the compound, gives CERo potential eligibility for priority review...
GCL Signs Term Sheet to Launch $14 Million Gaming, Culture Fund
GCL Signs Term Sheet to Launch $14 Million Gaming, Culture Fund
Sep 5, 2025
08:45 AM EDT, 09/05/2025 (MT Newswires) -- GCL Global Holdings ( GCL ) said Friday it has signed a non-binding term sheet with Harmony Capital to create the GCL Game and Cultural Industry Fund. The planned fund will target between 100 million Chinese renminbi ($14 million) and 150 million Chinese Renminbi and focus mainly on investments in China's gaming development...
Copyright 2023-2026 - www.financetom.com All Rights Reserved